EUVIMEDEUVIMED entdecken
Crossref

Pharmacogenomics of Tamoxifen: A Review

Zainab Hasan Naji, Ahmed Salih Sahib, Hassan Mahmood Mousa, Islam Hussein Abbas, Karrar Kadhim Mohsin

Journal of Healthcare · 24.09.2026 · 7 (1) · 172-174

DOI: 10.36959/569/478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Healthcare, online erschienen am 24.09.2026. Verfasst von Zainab Hasan Naji und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tamoxifen is a first-line endocrine treatment of estrogen receptor-positive breast cancer, which is commonly used both in treatment and prevention. Although this treatment is proven to be effective, interindividual variability in treatment response is significant and can result in tumour regression, disease recurrence, or drug-related side effects. The analysis of the relationship between genetic variation, drug response, and metabolism has created a vital tool for understanding this dynamic: pharmacogenomics. Tamoxifen is a prodrug that must be metabolised to the active metabolites 4-hydroxytamoxifen and endoxifen to be therapeutically effective [1,2]. Genetic polymorphisms also influence CYP enzyme activity, altering plasma concentrations of metabolites and drug efficacy. Though CYP2D6 is a widely investigated enzyme that forms endoxifen, other enzymes, including CYP3A4, CYP3A5, and CYP1B1, may also contribute to inter-individual differences in tamoxifen metabolism and clinical outcomes [3,4]. The paper presents a summary of the pharmacogenomics of tamoxifen, CYP2D6, and CYP1B1, including their polymorphisms, clinical significance, and implications for individualised treatment of breast cancer patients.

Zitieren

APA

Naji, Z. H., Sahib, A. S., Mousa, H. M., Abbas, I. H., & Mohsin, K. K. (2026). Pharmacogenomics of Tamoxifen: A Review. Journal of Healthcare, 7(1), 172-174. https://doi.org/10.36959/569/478

Vancouver

Naji ZH, Sahib AS, Mousa HM, Abbas IH, Mohsin KK. Pharmacogenomics of Tamoxifen: A Review. Journal of Healthcare. 2026;7(1):172-174. doi:10.36959/569/478

BibTeX
@article{Naji2026,
  author = {Naji, Zainab Hasan and Sahib, Ahmed Salih and Mousa, Hassan Mahmood and Abbas, Islam Hussein and Mohsin, Karrar Kadhim},
  title = {Pharmacogenomics of Tamoxifen: A Review},
  journal = {Journal of Healthcare},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {172--174},
  doi = {10.36959/569/478}
}
Kostenlos starten →